000			02396 a2200721 4500
005			20250518083144.0
264		0	_c20200706
008			202007s 0 0 eng d
022			_a1474-5488
024	7		_a10.1016/S1470-2045(20)30062-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aDummer, Reinhard
245	0	0	_aAdjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF _h[electronic resource]
260			_bThe Lancet. Oncology _c03 2020
300			_a358-372 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aOximes _xadministration & dosage
650	0	4	_aPrognosis
650	0	4	_aProto-Oncogene Proteins B-raf _xgenetics
650	0	4	_aPyridones _xadministration & dosage
650	0	4	_aPyrimidinones _xadministration & dosage
650	0	4	_aSalvage Therapy
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aSurvival Rate
650	0	4	_aYoung Adult
700	1		_aBrase, Jan C
700	1		_aGarrett, James
700	1		_aCampbell, Catarina D
700	1		_aGasal, Eduard
700	1		_aSquires, Matthew
700	1		_aGusenleitner, Daniel
700	1		_aSantinami, Mario
700	1		_aAtkinson, Victoria
700	1		_aMandalà, Mario
700	1		_aChiarion-Sileni, Vanna
700	1		_aFlaherty, Keith
700	1		_aLarkin, James
700	1		_aRobert, Caroline
700	1		_aKefford, Richard
700	1		_aKirkwood, John M
700	1		_aHauschild, Axel
700	1		_aSchadendorf, Dirk
700	1		_aLong, Georgina V
773	0		_tThe Lancet. Oncology _gvol. 21 _gno. 3 _gp. 358-372
856	4	0	_uhttps://doi.org/10.1016/S1470-2045(20)30062-0 _zAvailable from publisher's website
999			_c30585094 _d30585094